The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
jHcg8r77M91pkUge
